Hyperion Defi Inc (HYPD) Stock Price, Quote & News

Company Profile

Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in Chin...

Industry: Biotechnology

Sector: Healthcare

Phone: 917 289 1117

Website: hyperiondefi.com

Address:

295 Madison Avenue, Suite 2400, New York, United States

cheating_stock_investor Apr. 24 at 7:10 PM

$ROLR my friends here who want the prediction market opportunity check out $HYPE.X they have an upcoming defi protocol hip4 currently in test net soon to go live by june. $HYPD is the best way to invest in this if youre interested. The market is predicted to be 1 trillion so theres enough space for everyone. It's like the stock market in itself.

0 · Reply

cheating_stock_investor Apr. 24 at 3:56 PM

$HYPD looks like we based already for a new higher range. The licensing agreement is due in the next 60 days. Should take us to a base of 6 dollars per share after

0 · Reply

vert47 Apr. 21 at 2:07 PM

$HYPD 😤

0 · Reply

Jwa68 Apr. 18 at 9:43 PM

$HYPD Management matters... CEO Hyunsu Jung and CFO David Knox, are both exceptional executives. They do what they say and they have their goals completely aligned with shareholders. Their business model is highly differentiated with their "Tripple Dip" strategy, which they continue to execute. Their messaging clearly delineates them from their peers.

1 · Reply

StockScanners Apr. 18 at 3:15 AM

$HYPD keep watch if this holds above 4.40

0 · Reply

topstockalerts Apr. 18 at 2:22 AM

$HYPD this is grinding up nicely, not mad at it

0 · Reply

YorkMeister Apr. 17 at 11:08 PM

$HYPD still >50% NAV discount. SP should be $8 on $HYPX holding alone - $PURR follows NAV better. Further upside from revenue and commercialisation of eyenovia assets should take this closer to $10

0 · Reply

ford11 Apr. 17 at 7:50 PM

$AKBA $HYPD

0 · Reply

ford11 Apr. 17 at 7:43 PM

$HYPD Tic toc tic toc

0 · Reply

Chingying Apr. 17 at 7:36 PM

$HYPD 03/27/26 PT$ 8.25 Chardan 6.28 AI

0 · Reply

Hyperion DeFi Earnings Call Transcript: Q4 2025

Mar 26, 2026, 7:00 AM EDT - 4 weeks ago

Hyperion DeFi Reports 4Q and FY 2025 Financial Results with Quarter-over-Quarter Growth of +64% Revenue and +87% Adjusted Gross Profit

Mar 9, 2026, 8:00 AM EDT - 6 weeks ago

Hyperion DeFi Announces Private Lending Pool Built by HyperLend

Nov 13, 2025, 5:00 PM EST - 5 months ago

Hyperion DeFi Earnings Call Transcript: Q3 2025

Sep 29, 2025, 8:00 AM EDT - 7 months ago

Hyperion DeFi Announces Appointment of David Knox as Chief Financial Officer

Sep 27, 2025, 7:30 AM EDT - 7 months ago

Many crypto-treasury companies are trading for less than what their digital assets are worth. Is this a bargain or a big red flag?

ALTS MARA MSTR

Sep 25, 2025, 8:00 AM EDT - 7 months ago

Hyperion DeFi Adds $10M in HYPE to its Treasury Holdings

Sep 16, 2025, 8:00 AM EDT - 7 months ago

Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo

Aug 14, 2025, 10:16 AM EDT - 9 months ago

Kinetiq Announces iHYPE Launch with Hyperion DeFi as First Institutional Depositor

Aug 13, 2025, 4:30 PM EDT - 9 months ago

Hyperion DeFi Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:01 PM EDT - 9 months ago

Hyperion DeFi Provides Corporate Update and Reports Second Quarter 2025 Financial Results

Aug 8, 2025, 4:05 PM EDT - 9 months ago

Hyperion Defi to Report Second Quarter 2025 Results on Wednesday, August 13, 2025

Jul 29, 2025, 2:00 PM EDT - 9 months ago

Hyperion DeFi Transcript: Status Update

Jul 28, 2025, 8:00 AM EDT - 9 months ago

Hyperion DeFi Purchases Additional $5 Million in HYPE for Kinetiq iHYPE Strategy

Jul 17, 2025, 8:00 AM EDT - 10 months ago

Hyperion DeFi to Host Corporate Update Event to Discuss Strategic Evolution from Eyenovia and the Future of On-Chain Finance on July 29, 2025

Jul 14, 2025, 4:05 PM EDT - 10 months ago

Hyperion DeFi Adds $5 Million in HYPE to its Treasury Holdings

Jun 18, 2025, 2:04 PM EDT - 11 months ago

Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings

KIDZ LGHL

Jun 18, 2025, 8:32 AM EDT - 11 months ago

Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group

Jun 17, 2025, 3:54 PM EDT - 11 months ago

Eyenovia Surges on Crypto Announcement

Jun 17, 2025, 2:55 PM EDT - 11 months ago

Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy

May 19, 2025, 5:30 PM EDT - 1 year ago

Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results

Apr 10, 2025, 7:00 AM EDT - 1 year ago

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)

Mar 20, 2025, 7:00 AM EDT - 1 year ago

Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq

Feb 26, 2025, 7:00 AM EST - 1 year ago

Eyenovia Regains Compliance with All Nasdaq Continued Listing Requirements

Feb 24, 2025, 7:00 AM EST - 1 year ago

Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives

Feb 5, 2025, 7:00 AM EST - 1 year ago

Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device

Jan 28, 2025, 4:05 PM EST - 1 year ago

Eyenovia Announces 1-for-80 Reverse Stock Split

Jan 15, 2025, 7:00 AM EST - 1 year ago

Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders

Jan 6, 2025, 7:00 AM EST - 1 year ago

Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives

Dec 6, 2024, 8:00 AM EST - 1 year ago

Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering

Nov 22, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Restructuring Efforts

Nov 15, 2024, 1:15 PM EST - 1 year ago

Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline

Nov 15, 2024, 7:07 AM EST - 1 year ago

Eyenovia to discontinue late-stage study for eye drug

Nov 15, 2024, 7:00 AM EST - 1 year ago

Eyenovia Provides Update on Phase 3 CHAPERONE Study

Nov 12, 2024, 4:30 PM EST - 1 year ago

Hyperion DeFi Earnings Call Transcript: Q3 2024

Nov 7, 2024, 7:00 AM EST - 1 year ago

Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th

Oct 16, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo

Oct 1, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device

Sep 27, 2024, 8:30 AM EDT - 1 year ago

Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering

Sep 26, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery

Sep 9, 2024, 3:00 AM EDT - 1 year ago

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

Sep 5, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.

Sep 3, 2024, 7:00 AM EDT - 1 year ago

Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer

Aug 23, 2024, 11:42 AM EDT - 1 year ago

Eyenovia Announces Closing of Public Offering

Aug 22, 2024, 2:20 PM EDT - 1 year ago

Why Is Eye Disease Focused Eyenovia Stock Trading Higher On Thursday?

Aug 21, 2024, 9:29 AM EDT - 1 year ago

Eyenovia Announces Pricing of $5.14 Million Public Offering

Aug 20, 2024, 5:09 PM EDT - 1 year ago

Eyenovia, Inc. Announces Proposed Public Offering

Aug 12, 2024, 4:30 PM EDT - 1 year ago

Hyperion DeFi Earnings Call Transcript: Q2 2024

Aug 12, 2024, 4:05 PM EDT - 1 year ago

Eyenovia Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Eyenovia to Report Second Quarter 2024 Results on Monday, August 12th

Aug 7, 2024, 5:11 PM EDT - 1 year ago

Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

Aug 7, 2024, 8:00 AM EDT - 1 year ago

Formosa Pharma and Eyenovia Announce Initiation of Co-Development of Clobetasol Propionate Ophthalmic Suspension, 0.05%, for the treatment of Acute Dry Eye Disease in United States

Jul 30, 2024, 8:00 AM EDT - 1 year ago

Eyenovia & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease

Jul 23, 2024, 7:00 AM EDT - 1 year ago

Eyenovia and Senju Pharmaceutical Co., Ltd. Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease

Jul 1, 2024, 6:50 AM EDT - 1 year ago

NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities

Jun 28, 2024, 8:00 AM EDT - 1 year ago

Eyenovia Announces Pricing of $5M Registered Direct Offering

May 15, 2024, 4:30 PM EDT - 2 years ago

Hyperion DeFi Earnings Call Transcript: Q1 2024

Mar 18, 2024, 4:30 PM EDT - 2 years ago

Hyperion DeFi Earnings Call Transcript: Q4 2023

Nov 13, 2023, 4:30 PM EST - 2 years ago

Hyperion DeFi Earnings Call Transcript: Q3 2023

Aug 10, 2023, 4:30 PM EDT - 2 years ago

Hyperion DeFi Earnings Call Transcript: Q2 2023

May 11, 2023, 4:30 PM EDT - 3 years ago

Hyperion DeFi Earnings Call Transcript: Q1 2023

Mar 30, 2023, 4:30 PM EDT - 3 years ago

Hyperion DeFi Earnings Call Transcript: Q4 2022

Nov 10, 2022, 9:00 AM EST - 3 years ago

Hyperion DeFi Earnings Call Transcript: Q3 2022

cheating_stock_investor Apr. 24 at 7:10 PM

0 · Reply

cheating_stock_investor Apr. 24 at 3:56 PM

$HYPD looks like we based already for a new higher range. The licensing agreement is due in the next 60 days. Should take us to a base of 6 dollars per share after

0 · Reply

vert47 Apr. 21 at 2:07 PM

$HYPD 😤

0 · Reply

Jwa68 Apr. 18 at 9:43 PM

1 · Reply

StockScanners Apr. 18 at 3:15 AM

$HYPD keep watch if this holds above 4.40

0 · Reply

topstockalerts Apr. 18 at 2:22 AM

$HYPD this is grinding up nicely, not mad at it

0 · Reply

YorkMeister Apr. 17 at 11:08 PM

$HYPD still >50% NAV discount. SP should be $8 on $HYPX holding alone - $PURR follows NAV better. Further upside from revenue and commercialisation of eyenovia assets should take this closer to $10

0 · Reply

ford11 Apr. 17 at 7:50 PM

$AKBA $HYPD

0 · Reply

ford11 Apr. 17 at 7:43 PM

$HYPD Tic toc tic toc

0 · Reply

Chingying Apr. 17 at 7:36 PM

$HYPD 03/27/26 PT$ 8.25 Chardan 6.28 AI

0 · Reply

Chingying Apr. 17 at 7:31 PM

$HYPD Bullish trend

0 · Reply

ford11 Apr. 17 at 7:28 PM

$HYPD HoLD!!

0 · Reply

Jke_ Apr. 17 at 3:51 PM

$HYPD Is there any reason why it wouldn't go back to $15 the next coming months? Has there been dilution since?

1 · Reply

IntentionalTrades Apr. 17 at 3:27 PM

$HYPD Wasy cash out

0 · Reply

Jwa68 Apr. 17 at 2:44 PM

$HYPD Nice tape action.

0 · Reply

FonsieTrader Apr. 17 at 2:29 PM

$HYPD – Pressure building right under resistance 👀 Higher lows forming while price keeps testing $4.03–$4.25 → key level. TTM Squeeze shifting = momentum building after compression. RSI strong (66), MFI curling up, OBV trending higher → accumulation. Break + hold $4.25 and this can move fast toward $5.50–$6.00. Support: $3.80 👉 Clean setup. Watching closely.

0 · Reply

cheating_stock_investor Apr. 17 at 2:28 PM

$HYPD looks like someone knows two things We stay above 4 now that $HYPE.X is holding above 42, cash burn is managed, cash flow coming in from validator. And most importantly any day now the optijet deal will be signed for more cashflow and money to get more tokens.

0 · Reply

ford11 Apr. 17 at 2:22 PM

$HYPD

0 · Reply

cheating_stock_investor Apr. 15 at 5:33 PM

$HYPD $HYPE.X has based over 40 and now moving to 50. Everything is on track

1 · Reply

ford11 Apr. 15 at 2:27 PM

$HYPD

0 · Reply

ford11 Apr. 14 at 2:40 PM

$HYPD Break that shit!! Its time!!!

0 · Reply

Jwa68 Apr. 13 at 9:04 PM

$HYPD https://www.fintechweekly.com/magazine/articles/token-value-accrual-sustainable-crypto-economics-defi-2026

0 · Reply

Market Cap	44.77M
Revenue (ttm)	810,000.00
Net Income (ttm)	-45.31M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	1.38
Profit Margin	-5,593.83%
Debt to Equity Ratio	0.19

Volume	228,200
Avg Vol	350,814
Day's Range	N/A - N/A
Shares Out	11.39M
Stochastic %K	60%
Beta	2.62
Analysts	Sell
Price Target	$6.28